HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of coagulation factor XII in unexplained recurrent abortions in the Greek population.

AbstractOBJECTIVE:
To investigate the prevalence and clinical significance of congenital factor XII (FXII) deficiency in the South-European Caucasian (Greek) population in a cohort of women with recurrent spontaneous abortions (RSAs).
STUDY DESIGN:
One hundred women with a history of > or =2 RSAs of unexplained nature were compared to 100 age-matched, healthy controls with no history of thrombotic disease or adverse pregnancy outcomes, regarding FXII activity. Women were included in the RSA group if they had normal coagulation parameters and no congenital or acquired thrombophilia.
RESULTS:
Fifteen of 100 women with RSA had reduced FXII activity, whereas all controls had normal FXII activity. FXII activity was significantly lower in the RSA than in the control group (median 100.5, range 10-150 vs. median 104.2, range 58.3-143.2, p < 0.016 by Mann-Whitney test). FXII activity was positively correlated with age in both the RSA and the control groups (r = +0.1, p = 0.04 and r = +0.04, p = 0.2, respectively), but this correlation reached statistical significance in the RSA group only. A negative correlation between FXII activity and the number of abortions in the RSA group was found (r = -0.2, p = 0.03).
CONCLUSION:
Congenital FXII deficiency is strongly associated with RSA in the Greek population.
AuthorsSpyros Dendrinos, Aikaterini Deliveliotou, Anastasios Anastasiou, George K Creatsas
JournalThe Journal of reproductive medicine (J Reprod Med) 2014 Jan-Feb Vol. 59 Issue 1-2 Pg. 56-62 ISSN: 0024-7758 [Print] United States
PMID24597288 (Publication Type: Journal Article)
Chemical References
  • Factor XII
Topics
  • Abortion, Habitual (blood, etiology)
  • Adult
  • Factor XII (physiology)
  • Factor XII Deficiency (complications, congenital, epidemiology)
  • Female
  • Greece (epidemiology)
  • Humans
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: